Hexo Corp

HEXO-T

TSE:HEXO

1.84
0.13 (6.60%)
Hexo Corp, formerly Hydropothecary Corp, is a Canada-based company that creates and distributes products to serve the Canadian cannabis market. The Company operates with an approximately 300,000 square feet of production capacity. The Company serves the adult-use market under the HEXO brand, while it serves its medical cannabis clients through the Hydropothecary brand.
More at Wikipedia

Analysis and Opinions about HEXO-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
November 25, 2019
He avoids the cannabis space now. (He owned some early on.) The market here is too small here. He's keeping tabs on some names. It's still tax-loss selling now. He needs to see how these companies will be profitable. He'd rather buy the US weed stocks--a bigger market there. Avoid this space.
Show full opinionHide full opinion
Hexo Corp (HEXO-T)
November 25, 2019
He avoids the cannabis space now. (He owned some early on.) The market here is too small here. He's keeping tabs on some names. It's still tax-loss selling now. He needs to see how these companies will be profitable. He'd rather buy the US weed stocks--a bigger market there. Avoid this space.
PAST TOP PICK
PAST TOP PICK
June 28, 2019
(A Top Pick May 10/18, Up 42%) They've executed on time and on budget. Watch them when the derivatives market rolls out in October. They have a big supply deal for Quebec. A strong take-out candidate.
Show full opinionHide full opinion
Hexo Corp (HEXO-T)
June 28, 2019
(A Top Pick May 10/18, Up 42%) They've executed on time and on budget. Watch them when the derivatives market rolls out in October. They have a big supply deal for Quebec. A strong take-out candidate.
HOLD
HOLD
May 31, 2019
He owns a little along with warrants. They have a better valuation than some of the bigger players. They specialize in sprays and edible marijuana. He would be cautious about this space though. (Analysts’ price target is $11.50)
Show full opinionHide full opinion
Hexo Corp (HEXO-T)
May 31, 2019
He owns a little along with warrants. They have a better valuation than some of the bigger players. They specialize in sprays and edible marijuana. He would be cautious about this space though. (Analysts’ price target is $11.50)
PAST TOP PICK
PAST TOP PICK
May 1, 2019
(A Top Pick May 10/18, Up 112%) It was flying under the radar last year, but then they struck a supply deal with Quebec. They continue to execute well. They're looking for a new CFO as they enter a major production phase.
Show full opinionHide full opinion
Hexo Corp (HEXO-T)
May 1, 2019
(A Top Pick May 10/18, Up 112%) It was flying under the radar last year, but then they struck a supply deal with Quebec. They continue to execute well. They're looking for a new CFO as they enter a major production phase.
DON'T BUY
DON'T BUY
March 29, 2019
He does not cover the marijuana sector specifically but he does follow the sector. Generally, their revenues have been coming in far below guidance. They are priced on very high expectations. Need to be careful in this space. He expects there could be a lot more volatility.
Show full opinionHide full opinion
Hexo Corp (HEXO-T)
March 29, 2019
He does not cover the marijuana sector specifically but he does follow the sector. Generally, their revenues have been coming in far below guidance. They are priced on very high expectations. Need to be careful in this space. He expects there could be a lot more volatility.
SELL STRENGTH
SELL STRENGTH
February 22, 2019
Definitely not a buy and hold, but a trader stock. It has a good chance of returning to its past high of $9-10. Because of recent extreme highs and lows, shareholders who bought this high will sell-off when HEXO returns to its past high in order to break even. Sell it at $9.
Show full opinionHide full opinion
Hexo Corp (HEXO-T)
February 22, 2019
Definitely not a buy and hold, but a trader stock. It has a good chance of returning to its past high of $9-10. Because of recent extreme highs and lows, shareholders who bought this high will sell-off when HEXO returns to its past high in order to break even. Sell it at $9.
COMMENT
COMMENT
January 30, 2019

Will it listing in the US change the price? They announced they will be on the US exchange shortly. Pricing will adjust for US/CAD exchange.

Show full opinionHide full opinion
Hexo Corp (HEXO-T)
January 30, 2019

Will it listing in the US change the price? They announced they will be on the US exchange shortly. Pricing will adjust for US/CAD exchange.

DON'T BUY
DON'T BUY
January 28, 2019

We get confused that a Canadian company going to U.S. will create a U.S. audience, but suppose America doesn't like your company? He needs this to break above $7 and he expects it'll face resistance at $8.

Show full opinionHide full opinion
Hexo Corp (HEXO-T)
January 28, 2019

We get confused that a Canadian company going to U.S. will create a U.S. audience, but suppose America doesn't like your company? He needs this to break above $7 and he expects it'll face resistance at $8.

DON'T BUY
DON'T BUY
January 9, 2019

Doesn't own any of the marijuana producers, as the fundamentals don't warrant the prices. There will be a day of reckoning, which has probably already started. Large producers peaked before legalization, the small ones peaked last January/February. Reality check when these companies start missing sales and EBITDA, and the air pocket beneath the share price collapses, with a 50-60-70% downside. He'll reconsider when the dust settles, but that day is not today. (Analysts’ price target is $9.25)

Show full opinionHide full opinion
Hexo Corp (HEXO-T)
January 9, 2019

Doesn't own any of the marijuana producers, as the fundamentals don't warrant the prices. There will be a day of reckoning, which has probably already started. Large producers peaked before legalization, the small ones peaked last January/February. Reality check when these companies start missing sales and EBITDA, and the air pocket beneath the share price collapses, with a 50-60-70% downside. He'll reconsider when the dust settles, but that day is not today. (Analysts’ price target is $9.25)

WEAK BUY
WEAK BUY
November 27, 2018
He likes it. Not a cheap stock and the entire cannabis space is challenged. Not for the faint of heart, though. Hexo has good extraction technologies and he can see CBD-drinks doing very well in the future.
Show full opinionHide full opinion
Hexo Corp (HEXO-T)
November 27, 2018
He likes it. Not a cheap stock and the entire cannabis space is challenged. Not for the faint of heart, though. Hexo has good extraction technologies and he can see CBD-drinks doing very well in the future.
BUY
BUY
October 17, 2018

A billion dollar market cap that trades on 12 times earnings – low for this space, which can see 30 times earnings. It has lower cost production in Quebec and good labour rates. They sell a spray oil that is innovative, which provides for faster onset – and has been award winning. They have a joint venture with Molson-Coors.

Show full opinionHide full opinion
Hexo Corp (HEXO-T)
October 17, 2018

A billion dollar market cap that trades on 12 times earnings – low for this space, which can see 30 times earnings. It has lower cost production in Quebec and good labour rates. They sell a spray oil that is innovative, which provides for faster onset – and has been award winning. They have a joint venture with Molson-Coors.

BUY
BUY
October 4, 2018

He just added to it. He thinks the valuation is attractive compared to its peers. They keep lowering their costs and get a premium for their product. They did a good job in the extracted product market.

Show full opinionHide full opinion
Hexo Corp (HEXO-T)
October 4, 2018

He just added to it. He thinks the valuation is attractive compared to its peers. They keep lowering their costs and get a premium for their product. They did a good job in the extracted product market.

DON'T BUY
DON'T BUY
August 8, 2018

The chart looks decent and volume has been strong. You could add to your position with a $4.00 stop. Towards the end of the year, when real earnings occur, there will be a market re-evaluation of this space in general. He would not invest in this space for his clients. (Analysts’ price target is $8.50)

Show full opinionHide full opinion
Hexo Corp (HEXO-T)
August 8, 2018

The chart looks decent and volume has been strong. You could add to your position with a $4.00 stop. Towards the end of the year, when real earnings occur, there will be a market re-evaluation of this space in general. He would not invest in this space for his clients. (Analysts’ price target is $8.50)

DON'T BUY
DON'T BUY
June 29, 2018

Doing right thing in signing supply agreements with Quebec government. Could be a takeout. Doesn’t like that they haven’t signed international agreements, plus the industry is selling off as a whole. He’d stay with the bigger players. Better ways to play the sector.

Show full opinionHide full opinion
Hexo Corp (HEXO-T)
June 29, 2018

Doing right thing in signing supply agreements with Quebec government. Could be a takeout. Doesn’t like that they haven’t signed international agreements, plus the industry is selling off as a whole. He’d stay with the bigger players. Better ways to play the sector.

DON'T BUY
DON'T BUY
May 28, 2018

He already bought and sold it, but wouldn't buy it here. It's well-funded and well-run. THCX was waiting for a contract from the Quebec government, so it's a good story and will be profitable. But it's had a good run for now. He'd rather buy HMMJ--individual companies are so volatile.

Show full opinionHide full opinion
Hexo Corp (HEXO-T)
May 28, 2018

He already bought and sold it, but wouldn't buy it here. It's well-funded and well-run. THCX was waiting for a contract from the Quebec government, so it's a good story and will be profitable. But it's had a good run for now. He'd rather buy HMMJ--individual companies are so volatile.

Showing 1 to 15 of 19 entries